Results 31 to 40 of about 10,783,090 (304)

FOLLOW THE DIRECTIONS TO GENERATE A GREAT HYPOTHESIS!

open access: yesCentral Asian Journal of Medical Hypotheses and Ethics, 2021
FOLLOW THE DIRECTIONS TO GENERATE A GREAT HYPOTHESIS!
Ilke Coskun Benlidayi
doaj   +1 more source

Carcinomas and Carcinoid Tumors of the Lungs and Bronchi in Children and Adolescents: The EXPeRT Recommendations

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Primary lung carcinomas and bronchial carcinoid tumors (BC) are very rare malignancies in childhood. While typical BC and mucoepidermoid carcinomas are mostly low‐grade, localized tumors with a more favorable prognosis than in adults, necessitating avoidance of overtreatment, adenocarcinomas of the lung are often diagnosed at advanced disease ...
Michael Abele   +19 more
wiley   +1 more source

Research Status and Future Development of Biomass Liquid Fuels

open access: yesBioResources, 2021
Due to the combined pressures of energy shortage and environmental degradation, bio-liquid fuels have been widely studied as a green, environmentally friendly, renewable petroleum alternative.
Ji Zhang   +4 more
doaj   +1 more source

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

Health‐Related Quality of Life and Symptom Severity Among Patients With PIK3CA‐Related Overgrowth Spectrum: A Mixed‐Methods Study to Understand Real‐World Experience With Alpelisib Treatment

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background PIK3CA‐related overgrowth spectrum (PROS) includes several rare overgrowth disorders resulting from somatic gain‐of‐function mutations in PIK3CA. Despite treatment advances, including the recent approval of alpelisib for PROS in the United States, literature detailing the patient experience with PROS is limited.
Vamsi Bollu   +8 more
wiley   +1 more source

National platform for Rare Diseases Data Registry of Japan

open access: yesLearning Health Systems, 2019
Introduction In Japan, there are approximately 300 projects conducting research on rare diseases supported by the Ministry of Health, Labour and Welfare of Japan (MHLW) and the Japan Agency for Medical Research and Development (AMED).
Yoshihiko Furusawa   +6 more
doaj   +1 more source

Major Advances in Monkeypox Vaccine Research and Development – An Update

open access: yesJournal of Pure and Applied Microbiology, 2022
Monkeypox (MPX) is a zoonotic disease that is endemic to the western and central regions of Africa and it is caused by monkeypox virus (MPXV), which is classified as a member of the Poxviridae family, specifically the Chordopoxvirinae subfamily, and the ...
Deepak Chandran   +16 more
doaj   +1 more source

The value chain of research and development in the national program for innovation [PDF]

open access: yesInterdisciplinary Studies in the Humanities, 2020
فرایندهای اصلیِ اقتصاد دانش‌بنیان، عبارت‌اند از تولید، توزیع، انتقال، و کاربرد دانش. با گسترش روزافزون علم و دانش، و توسعۀ محدودۀ به‌کارگیری آن، تحقیق و توسعه، کلیدی‌ترین رمز موفقیت صنایع در عصر حاضر به‌شمار می‌آید. مقالۀ حاضر، به‌گونه‌ای میان‌رشته‌ای در
M. Molavvani   +4 more
doaj   +1 more source

Developing the Research Hypothesis

open access: yesJournal of Investigative Surgery, 2011
The research hypothesis is needed for a sound and well-developed research study. The research hypothesis contributes to the solution of the research problem. Types of research hypotheses include inductive and deductive, directional and non-directional, and null and alternative hypotheses.
Alexander H, Toledo   +2 more
openaire   +2 more sources

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background 131I‐metaiodobenzylguanidine (131I‐MIBG) radiotherapy is a key treatment for relapsed and refractory (R/R) neuroblastoma (NB). Patients with R/R disease treated in the modern era are increasingly exposed to anti‐GD2 immunotherapy, which exerts selective pressure and may modify both tumor cell state and microenvironment.
Benjamin J. Lerman   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy